Critical Analysis: SP Plus (SP) and The Competition

SP Plus (NASDAQ: SP) is one of 120 publicly-traded companies in the “OTHER CONS DISC” industry, but how does it compare to its peers? We will compare SP Plus to related companies based on the strength of its earnings, risk, profitability, institutional ownership, dividends, valuation and analyst recommendations.

Analyst Recommendations

How to Become a New Pot Stock Millionaire

This is a breakdown of recent ratings and price targets for SP Plus and its peers, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SP Plus 0 0 1 0 3.00
SP Plus Competitors 436 2337 3496 148 2.52

SP Plus presently has a consensus target price of $42.00, suggesting a potential upside of 20.52%. As a group, “OTHER CONS DISC” companies have a potential upside of 15.31%. Given SP Plus’ stronger consensus rating and higher probable upside, research analysts plainly believe SP Plus is more favorable than its peers.

Profitability

This table compares SP Plus and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
SP Plus 2.55% 12.87% 4.97%
SP Plus Competitors -7.86% 5.55% 2.72%

Valuation and Earnings

This table compares SP Plus and its peers revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
SP Plus $1.59 billion $41.20 million 18.94
SP Plus Competitors $1.75 billion $88.20 million 24.81

SP Plus’ peers have higher revenue and earnings than SP Plus. SP Plus is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Volatility & Risk

SP Plus has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500. Comparatively, SP Plus’ peers have a beta of -31.73, indicating that their average share price is 3,273% less volatile than the S&P 500.

Insider & Institutional Ownership

96.4% of SP Plus shares are owned by institutional investors. Comparatively, 57.0% of shares of all “OTHER CONS DISC” companies are owned by institutional investors. 1.4% of SP Plus shares are owned by company insiders. Comparatively, 21.1% of shares of all “OTHER CONS DISC” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

SP Plus beats its peers on 8 of the 13 factors compared.

SP Plus Company Profile

SP Plus Corporation (SP Plus) is a provider of parking management, ground transportation and other ancillary services to commercial, institutional and municipal clients in the United States, Puerto Rico and Canada. The Company’s segments include Region One (Urban), Region Two (Airport transportation), Region Three and Other. Region One (Urban) encompasses its services in healthcare facilities, municipalities, including government facilities, hotels, commercial real estate, residential communities, retail, colleges and universities, as well as ancillary services such as shuttle and transportation services, valet services, taxi and livery dispatch services. Region Two (Airport transportation) encompasses its services at all major airports, as well as ancillary services, which includes shuttle and transportation services and valet services. Region Three encompasses other operating segments, including USA Parking and event planning, including shuttle and transportation services.

Receive News & Ratings for SP Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SP Plus and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Proteostasis Therapeutics  Stock Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Proteostasis Therapeutics Stock Price
FTD Companies  Getting Somewhat Positive Press Coverage, Report Shows
FTD Companies Getting Somewhat Positive Press Coverage, Report Shows
Koovs  Stock Price Up 28.2%
Koovs Stock Price Up 28.2%
Rigel Pharmaceuticals   Shares Down 6.5%
Rigel Pharmaceuticals Shares Down 6.5%
Dicerna Pharmaceuticals  Shares Up -6.6%
Dicerna Pharmaceuticals Shares Up -6.6%
Barnes & Noble  & Big 5 Sporting Goods  Head to Head Review
Barnes & Noble & Big 5 Sporting Goods Head to Head Review


© 2006-2018 Ticker Report. Google+.